LivaNova PLC risk profile

36 Normal where most of the sector sits

Measured 1 September 2026 from LIVN's filed statements. Recomputed nightly.

36 (Normal), driven by Competitive position at 47, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation28NormalStableOne-year price volatility — 36.7%
Operating pressure19ContainedStableCosts outgrowing revenue — -2.4 percentage points
Cash conversion26NormalWorseningCapital spending against operating cash — 0.32x
Leverage and coverage46ElevatedWorseningInterest cover — -2.27x
Competitive position47ElevatedStableOperating-margin gap against peers — +6.4 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for LivaNova PLC